Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations

Documenti analoghi

• Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)
  di: Lecarpentier, Julie, et al.
  Pubblicazione: (2012)
• Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec
  di: Dorval, Michel, et al.
  Pubblicazione: (2011)
• BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis
  di: Julian-Reynier, Claire, et al.
  Pubblicazione: (2012)
• Disclosure of research results: a randomized study on GENEPSO‐PS cohort participants
  di: Mancini, Julien, et al.
  Pubblicazione: (2015)
• GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers
  di: Lesueur, Fabienne, et al.
  Pubblicazione: (2018)